209 related articles for article (PubMed ID: 32489262)
1. Baseline staging imaging for distant metastasis in women with stages I, II, and III breast cancer.
Arnaout A; Varela NP; Allarakhia M; Grimard L; Hey A; Lau J; Thain L; Eisen A
Curr Oncol; 2020 Apr; 27(2):e123-e145. PubMed ID: 32489262
[TBL] [Abstract][Full Text] [Related]
2. Baseline staging tests in primary breast cancer: a practice guideline.
Myers RE; Johnston M; Pritchard K; Levine M; Oliver T;
CMAJ; 2001 May; 164(10):1439-44. PubMed ID: 11387916
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques.
Koolen BB; Vrancken Peeters MJ; Aukema TS; Vogel WV; Oldenburg HS; van der Hage JA; Hoefnagel CA; Stokkel MP; Loo CE; Rodenhuis S; Rutgers EJ; Valdés Olmos RA
Breast Cancer Res Treat; 2012 Jan; 131(1):117-26. PubMed ID: 21935602
[TBL] [Abstract][Full Text] [Related]
4. Whole-body
Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
[TBL] [Abstract][Full Text] [Related]
5. Unwarranted imaging for distant metastases in patients with newly diagnosed ductal carcinoma in situ and stage I and II breast cancer.
Lupichuk S; Tilley D; Surgeoner B; King K; Joy AA
Can J Surg; 2020 Feb; 63(2):E100-E109. PubMed ID: 32109016
[TBL] [Abstract][Full Text] [Related]
6. Use and Yield of Baseline Imaging and Laboratory Testing in Stage II Breast Cancer.
Bychkovsky BL; Guo H; Sutton J; Spring L; Faig J; Dagogo-Jack I; Battelli C; Houlihan MJ; Yeh TC; Come SE; Lin NU
Oncologist; 2016 Dec; 21(12):1495-1501. PubMed ID: 27551013
[TBL] [Abstract][Full Text] [Related]
7. Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.
Hogan MP; Goldman DA; Dashevsky B; Riedl CC; Gönen M; Osborne JR; Jochelson M; Hudis C; Morrow M; Ulaner GA
J Nucl Med; 2015 Nov; 56(11):1674-80. PubMed ID: 26294295
[TBL] [Abstract][Full Text] [Related]
8. Screening for distant metastases in patients with ipsilateral breast tumor recurrence: the impact of different imaging modalities on distant recurrence-free interval.
Poodt IGM; Schipper RJ; de Greef BTA; Vugts G; Maaskant-Braat AJG; Jansen FH; Wyndaele DNJ; Voogd AC; Nieuwenhuijzen GAP;
Breast Cancer Res Treat; 2019 Jun; 175(2):419-428. PubMed ID: 30955183
[TBL] [Abstract][Full Text] [Related]
9.
Ulaner GA; Juarez J; Riedl CC; Goldman DA
J Nucl Med; 2019 Apr; 60(4):472-477. PubMed ID: 30237211
[No Abstract] [Full Text] [Related]
10. Evaluation of the evidence on staging imaging for detection of asymptomatic distant metastases in newly diagnosed breast cancer.
Brennan ME; Houssami N
Breast; 2012 Apr; 21(2):112-23. PubMed ID: 22094116
[TBL] [Abstract][Full Text] [Related]
11. Staging PET-CT Scanning Provides Superior Detection of Lymph Nodes and Distant Metastases than Traditional Imaging in Locally Advanced Breast Cancer.
Garg PK; Deo SV; Kumar R; Shukla NK; Thulkar S; Gogia A; Sharma DN; Mathur SR
World J Surg; 2016 Aug; 40(8):2036-42. PubMed ID: 27220508
[TBL] [Abstract][Full Text] [Related]
12. Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.
Fuster D; Duch J; Paredes P; Velasco M; Muñoz M; Santamaría G; Fontanillas M; Pons F
J Clin Oncol; 2008 Oct; 26(29):4746-51. PubMed ID: 18695254
[TBL] [Abstract][Full Text] [Related]
13. [Detection of metastases in breast cancer patients: comparison of FDG PET with chest X-ray, bone scintigraphy and ultrasound of the abdomen].
Dose-Schwarz J; Mahner S; Schirrmacher S; Jenicke L; Müller V; Habermann CR; Brenner W
Nuklearmedizin; 2008; 47(3):97-103. PubMed ID: 18493688
[TBL] [Abstract][Full Text] [Related]
14. The impact of PET/CT imaging performed in the early postoperative period on the management of breast cancer patients.
Sen F; Akpinar AT; Ogur U; Duman G; Tamgac F; Alper E
Nucl Med Commun; 2013 Jun; 34(6):571-6. PubMed ID: 23549550
[TBL] [Abstract][Full Text] [Related]
15. Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer.
Mahner S; Schirrmacher S; Brenner W; Jenicke L; Habermann CR; Avril N; Dose-Schwarz J
Ann Oncol; 2008 Jul; 19(7):1249-1254. PubMed ID: 18356138
[TBL] [Abstract][Full Text] [Related]
16. [What do clinicians do with the results of the systematic staging imaging at the time of the breast cancer diagnosis?].
Turpin A; Mailliez A; Vennin P; Bonneterre J
Gynecol Obstet Fertil; 2014 May; 42(5):325-30. PubMed ID: 24411340
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of 18F-FDG PET/CT in low 18F-FDG-avidity breast cancer subtypes: comparison with breast US and MRI.
Park HL; Yoo IR; O JH; Kim H; Kim SH; Kang BJ
Nucl Med Commun; 2018 Jan; 39(1):35-43. PubMed ID: 28984814
[TBL] [Abstract][Full Text] [Related]
18. The role of FDG PET/CT in detection of distant metastasis in theinitial staging of breast cancer.
Aliyev A; Yilmaz Aksoy S; Özhan M; Ekmekçioğlu Ö; Vatankulu B; Kocael PÇ; Sağer MS; Erkan ME; Sönmezoğlu K; Halaç M
Turk J Med Sci; 2016 Feb; 46(2):349-60. PubMed ID: 27511496
[TBL] [Abstract][Full Text] [Related]
19. (18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer.
Ulaner GA; Castillo R; Goldman DA; Wills J; Riedl CC; Pinker-Domenig K; Jochelson MS; Gönen M
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1937-44. PubMed ID: 27129866
[TBL] [Abstract][Full Text] [Related]
20. A two-way comparison of whole-body 18FDG PET-CT and whole-body contrast-enhanced MRI for distant metastasis staging in patients with malignant tumors: a meta-analysis of 13 prospective studies.
Li J; Zhou H; Zhang X; Song F; Pang X; Wei Z
Ann Palliat Med; 2020 Mar; 9(2):247-255. PubMed ID: 32233618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
